Immunosupressive analogues and derivatives of succinylacetone

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514547, 514557, 514675, 514578, A61K 3122, A61K 3119, A61K 3112

Patent

active

048958727

ABSTRACT:
Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: ##STR1## and that have immunosuppressive activity both in vivo and in vitro based on their activities in cellular immunologic assays and adjuvant induced arthritis in rats, respectively.

REFERENCES:
patent: 4670467 (1987-06-01), Hess et al.
patent: 4760090 (1988-07-01), Nisser
patent: 4764531 (1988-08-01), Nisser
patent: 4835185 (1989-05-01), Nisser
Tschudy, D. et al., 1982, Chem. Abstracts, 96:210579d.
Weinback, E. D. et al., 1985, Chem. Abstracts, 103:35547f.
Beaumont, C. et al., 1986, Chem. Abstract, 105:150346t.
Hoult, R. C. et al., 1986, Chem. Abstracts, 105:222421p.
Hamilton, J. W. et al., 1988, Chem. Abstracts, 109:167885y.
Skolik, S. A. et al., 1988, Chem. Abstracts, 109:18322n.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immunosupressive analogues and derivatives of succinylacetone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunosupressive analogues and derivatives of succinylacetone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosupressive analogues and derivatives of succinylacetone will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-645512

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.